CervoMed (CRVO)
NASDAQ:CRVO
Holding CRVO?
Track your performance easily

CervoMed (CRVO) Income Statement

975 Followers

CervoMed Income Statement

Last quarter (Q2 2024), CervoMed's total revenue was $3.29M, an increase of 91.23% from the same quarter last year. In Q2, CervoMed's net income was $-2.32M. See CervoMed’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 12.78M$ 7.14M----
Cost of Revenue
------
Gross Profit
$ 12.78M$ 7.14M----
Operating Expense
$ 12.48M$ 7.81M$ 3.48M$ 16.04M$ 15.97M$ 11.55M
Operating Income
$ -6.84M$ -7.81M$ -3.48M$ -24.68M$ -15.97M$ -11.55M
Net Non Operating Interest Income Expense
$ 625.15K$ 219.43K$ 61.64K$ 137.49K$ 114.26K$ 85.30K
Other Income Expense
$ 4.78M$ 5.42M$ 2.39M$ 8.64M--
Pretax Income
$ -797.63K$ -2.17M$ -5.80M$ -24.54M$ -15.86M$ -11.47M
Tax Provision
---$ -443.89K$ -1.68M$ 332.88K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -797.63K$ -2.17M$ -5.80M$ -24.10M$ -16.14M$ -11.80M
Basic EPS
$ 2.28$ -0.82$ -11.48$ -0.38$ -0.45$ -2.64
Diluted EPS
$ 2.28$ -0.82$ -11.48$ -0.57$ -0.68$ -2.64
Basic Average Shares
$ 22.80M$ 2.66M$ 1.36M$ 64.26M$ 35.86M$ 4.47M
Diluted Average Shares
$ 22.80M$ 2.66M$ -5.00$ 42.27M$ 23.90M$ 1.00
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 19.63M$ 7.81M$ 3.48M$ 16.04M$ 15.97M$ 11.55M
Net Income From Continuing And Discontinued Operation
$ -797.63K$ -2.17M$ -5.80M$ -24.10M$ -14.19M$ -11.80M
Normalized Income
$ 892.82K$ -1.72M----
Interest Expense
------
EBIT
$ -4.35M$ -2.17M$ -5.80M$ -24.54M$ -15.97M$ -11.47M
EBITDA
$ -4.35M$ -2.17M$ -5.80M$ -24.45M$ -15.87M$ -11.37M
Currency in USD

CervoMed Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis